Rocket Pharmaceuticals Cash from Financing (TTM) Insights

Rocket Pharmaceuticals Inc (RCKT)

22.79 +0.26 (+1.15%) USD | NASDAQ | May 02, 16:00

22.79 0.00 (0.00%) Pre-Market: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	208.40M
September 30, 2023	316.45M
June 30, 2023	156.49M
March 31, 2023	173.56M
December 31, 2022	155.29M
September 30, 2022	47.98M
June 30, 2022	45.10M
March 31, 2022	28.96M
December 31, 2021	37.68M
September 30, 2021	318.99M
June 30, 2021	292.86M
March 31, 2021	291.90M
December 31, 2020	282.99M
September 30, 2020	92.95M
June 30, 2020	92.47M
March 31, 2020	177.67M
December 31, 2019	177.79M
September 30, 2019	160.22M
June 30, 2019	160.34M

Date	Value
March 31, 2019	74.98M
December 31, 2018	153.50M
September 30, 2018	53.28M
June 30, 2018	53.09M
March 31, 2018	56.99M
December 31, 2017	0.019M
September 30, 2017	25.62M
June 30, 2017	74.34M
March 31, 2017	74.63M
December 31, 2016	53.08M
September 30, 2016	52.94M
June 30, 2016	78.22M
March 31, 2016	74.00M
December 31, 2015	125.52M
September 30, 2015	126.70M
June 30, 2015	52.04M
March 31, 2015	52.08M
December 31, 2014	0.568M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

28.96M

Minimum

Mar 2022

318.99M

Maximum

Sep 2021

169.37M

Average

160.34M

Median

Jun 2019

Cash from Financing (TTM) Benchmarks